Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)
This study has been completed.
Study NCT00287157 Information provided by Teva R&D Initiative
First Received: February 2, 2006 Last Updated: January 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Traumatic Brain Injury
Additional conditions recognized in this trial
Brain Injuries
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Craniocerebral Trauma
Disorders of Environmental Origin
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
Sublingual Tizanidine HCl
Additional drug interventions recognized in this trial
Tizanidine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Analgesics
Anticonvulsants
Autonomic Agents
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Muscle Relaxants, Central
Neuromuscular Agents
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Teva R& Initiative
Back to top of Main Content
